N-((2S,4S)-1-(4-(2-(3,5-dimethylisothiazol-4-yl)ethyl)piperidin-1-ylsulfonyl)-4-(5-fluoropyrimidin-2-yl)-2-methylpentan-2-yl)-N-hydroxyformamide

InChIKey	`YAQNYFRHXMKRGE-HJPURHCSSA-N`
Compound Name	N-((2S,4S)-1-(4-(2-(3,5-dimethylisothiazol-4-yl)ethyl)piperidin-1-ylsulfonyl)-4-(5-fluoropyrimidin-2-yl)-2-methylpentan-2-yl)-N-hydroxyformamide
Canonical SMILES	`Cc1nsc(C)c1CCC1CCN(S(=O)(=O)C[C@](C)(C[C@H](C)c2ncc(F)cn2)N(O)C=O)CC1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	9.59
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O75173	ADAMTS4	Homo sapiens	Human	PF17771 PF19236 PF05986 PF01421 PF00090	9.6	IC50	ChEMBL;BindingDB
P08253	MMP2	Homo sapiens	Human	PF00040 PF00045 PF00413	Clinical	TTD_MultiTarget	TTD_MultiTarget
P18843	nadE	Escherichia coli (strain K12)	Pathogen	PF02540	Clinical	TTD_MultiTarget	TTD_MultiTarget